Literature DB >> 23479665

Impression, sunset.

Marc Humbert.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23479665     DOI: 10.1161/CIRCULATIONAHA.113.001460

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.

Authors:  Henrik Ten Freyhaus; Eva M Berghausen; Wiebke Janssen; Maike Leuchs; Mario Zierden; Kirsten Murmann; Anna Klinke; Marius Vantler; Evren Caglayan; Tilmann Kramer; Stephan Baldus; Ralph T Schermuly; Michelle D Tallquist; Stephan Rosenkranz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

2.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

3.  Drug repositioning in pulmonary arterial hypertension: challenges and opportunities.

Authors:  Daniel Grinnan; Cory Trankle; Adam Andruska; Bruce Bloom; Edda Spiekerkoetter
Journal:  Pulm Circ       Date:  2019 Jan-Mar       Impact factor: 3.017

4.  Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension.

Authors:  Rudolf Speich; Ursula Treder; Guido Domenighetti; Lars C Huber; Silvia Ulrich
Journal:  Int J Clin Pharm       Date:  2013-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.